Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I

被引:58
作者
Abdel-Mottaleb, Mona M. A. [1 ,2 ]
Lamprecht, Alf [1 ,3 ]
机构
[1] Univ Bonn, Lab Pharmaceut Technol & Biopharmaceut, Inst Pharm, D-53121 Bonn, Germany
[2] Ain Shams Univ, Dept Drug Technol, Fac Pharm, Cairo, Egypt
[3] Univ Franche Comte, Lab Pharmaceut Engn, F-25030 Besancon, France
关键词
SUSTAINED-RELEASE; SYSTEMS; LIPOSOMES; NANOCAPSULES; NANOPARTICLES; DIALYSIS; DELIVERY; GELS;
D O I
10.3109/03639045.2010.502534
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Recently the use of colloidal carriers as drug delivery systems is gaining more attention. Evaluation of the in vitro drug release is considered an important step during the development and quality control of such systems. Therefore, there is a need for a standard test technique to study in vitro drug release from colloidal systems. Methods: The glass basket dialysis method was performed by a modification to the USP dissolution apparatus I by replacing the baskets with glass cylinders closed at the lower end by dialysis membrane. This method was characterized for the essential test parameters and compared to the dialysis bags technique using different types of colloidal drug carriers, namely liposomes, polymeric, and lipid nanoparticles. Results: The method proved to be more discriminating than the conventional dialysis bag method and allowed for better comparison between different formulation parameters or experimental conditions. In general, the design is easy to perform, simple, and available in all pharmaceutical laboratories under the same setup. Conclusion: The described method is a step toward standardized dissolution tests on colloidal drug delivery systems and the possible comparability of results.</.
引用
收藏
页码:178 / 184
页数:7
相关论文
共 24 条
[1]  
Abdel-Mottaleb MMA, 2009, DRUG DEV IND PHARM, V35, P311, DOI [10.1080/03639040802325893, 10.1080/03639040802325893 ]
[2]   Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers [J].
Calvo, P ;
VilaJato, JL ;
Alonso, MJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (05) :530-536
[3]  
Chidambaram N, 1999, AAPS PHARMSCI, V1
[4]   Methods to assess in vitro drug release from injectable polymeric particulate systems [J].
D'Souza, SS ;
DeLuca, PP .
PHARMACEUTICAL RESEARCH, 2006, 23 (03) :460-474
[5]  
Diebold S, 2005, PHARM DISSOLUTION TE, P127
[6]   IN-VITRO EVALUATION OF DRUG-RELEASE KINETICS FROM LIPOSOMES BY FRACTIONAL DIALYSIS [J].
HENRIKSEN, I ;
SANDE, SA ;
SMISTAD, G ;
AGREN, T ;
KARLSEN, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 119 (02) :231-238
[7]   EVALUATION OF CARRIER CAPACITY AND RELEASE CHARACTERISTICS FOR POLY(BUTYL 2-CYANOACRYLATE) NANOPARTICLES [J].
ILLUM, L ;
KHAN, MA ;
MAK, E ;
DAVIS, SS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 30 (01) :17-28
[8]   New lipid nanocapsules exhibit sustained release properties for amiodarone [J].
Lamprecht, A ;
Bouligand, Y ;
Benoit, JP .
JOURNAL OF CONTROLLED RELEASE, 2002, 84 (1-2) :59-68
[9]   In vitro drug release mechanism and drug loading studies of cubic phase gels [J].
Lara, MG ;
Bentley, MVLB ;
Collett, JH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 293 (1-2) :241-250
[10]  
Leavy MY, 1990, INT J PHARMACEUT, V66, P29